LAMP1 and breast cancer: With all cell lines, the TetraKE induced variable but higher NK cell CD107a expression compared to controls (p<0.001) and with the breast cancer cell line BT-474, 1615EpCAM133 was significantly superior compared to EpCAM16 BiKE (p<0.05).